Germany
Japan
United Kingdom
China
USD 630.00
2 Weeks
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Antibodies
View as table Download
Recombinant Anti-CD40L (Clone AT161-8)
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40L (Clone AT161-10)
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone chi220)
| Applications | Bl |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40L (Clone MR1)
| Applications | Bl, FC, FN |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD40L (Clone MR1)
| Applications | Bl, FC, FN |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD154 (Clone YMF323.6)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-CD154 (Clone IDEC-131 (Toralizumab))
| Applications | IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- CD40LG
Isotypes
- IgG, kappa
Clonalities
- Monoclonal